State Street SPDR S&P Pharmaceuticals ETFXPH

SPDRSectorsHealth Care#93 of 264 by YTD

$64.30

+1.1% last session

+15.1% YTD

Data as of 11/3/20264:00 PM ET · End-of-day

Dividend-adjusted total return · S&P 500 uses VOO · Aug 5, 2026 – Nov 3, 2026XPHS&P 500 · VOO

Returns	1D	1M	3M	YTD	1Y	3Y	5Y	MAX
Total return	+1.1%	+1.0%	−8.1%	+15.1%	+30.1%	+87.9%	+43.0%	+419.8%
Peer average	+0.6%	+4.0%	+6.1%	+21.0%	+29.0%	+81.2%	+28.9%	—
S&P 500 · VOO	+0.3%	−2.6%	−1.7%	+11.5%	+11.9%	+90.9%	+77.5%	—

Key Statistics

Open all fund facts →

AUM: $459M
Expense ratio: 0.35%
Distribution yield: 0.4%
NAV: $63.72
Volume: 728K
Avg. volume 30D: 223K
High today: $65.12
Low today: $64.03
Previous close: $63.61
52-week high: $74.35
52-week low: $47.60
Our risk indicator: 4/5

XPH in One Breath

XPH Among Health Care ETFs

YTD

#1ARKGARK+70.9%$2.2B

#2IDNAiShares+62.8%$340M

#3BBHVanEck+35.0%$525M

#4FTXHFirst Trust+33.8%$1.2B

#5XHSSPDR+32.9%$229M

#6BBPVirtus+29.5%$132M

#7XBISPDR+27.2%$10.5B

#8IHEiShares+26.9%$1.6B

#23XPHSPDR+15.1%$459M

End-of-day Nov 4, 2026 · 33 Health care ETFs by YTD

$10,000 in XPH

$10,000 in XPH became

$14,298

In the S&P 500 (VOO)

$17,749

Total return, dividends in · Oct 26, 2021 – Nov 3, 2026 · S&P 500 uses VOO

XPH’s Top Holdings

Today

MANEVeradermics2.9%XERS2.8%PCRX2.5%AMRX2.5%LLY2.4%VTRS2.3%MAZE2.3%SEPN2.2%PRGO2.2%LGND2.2%RPRX2.2%PFE2.1%ZTS2.1%ANIP2.1%JNJ2.0%INDV2.0%OGN2.0%INVA2.0%COLL2.0%PBH2.0%DFTX2.0%SUPN2.0%

MANEVeradermics2.9%XERS2.8%PCRX2.5%AMRX2.5%LLY2.4%VTRS2.3%MAZE2.3%SEPN2.2%PRGO2.2%LGND2.2%RPRX2.2%PFE2.1%

BiotechnologyDrug Manufacturers - SpecialtyDrug Manufacturers - GeneralMedical - Pharmaceuticals

SPDR XPH · 62 holdings · top 22 shown · tile size = share of the fund · as of Nov 1, 2026

What XPH Holds

Today

Biotechnology51.1%

MANE 2.9 · XERS 2.8 · MAZE 2.3 · SEPN 2.2 · LGND 2.2 · INVA 2.0 · DFTX 2.0

Drug Manufacturers - Specialty & Generic29.5%

PCRX 2.5 · AMRX 2.5 · VTRS 2.3 · PRGO 2.2 · ZTS 2.1 · ANIP 2.1 · INDV 2.0

Drug Manufacturers - General12.5%

LLY 2.4 · PFE 2.1 · JNJ 2.0 · OGN 2.0 · MRK 2.0 · BMY 1.9

Medical - Pharmaceuticals6.9%

RPRX 2.2 · PBH 2.0 · CORT 1.5 · LQDA 1.3

SPDR XPH · share of the fund by industry · as of Nov 1, 2026

Veradermics’ Share of XPH

Today

2.9%

$29 of every $1,000 in XPH is Veradermics

Veradermics held by XPH

$13.1M

Most Veradermics per dollar

LFSC4.1%

SBIO3.7%

XPH2.9%

SPDR XPH · each square = $10 of $1,000 · as of Nov 1, 2026

XPH’s Share of Health Care ETFs

Today

0.4%

of the $109B in 39 Health care ETFs

XPH$459M0.4%

XLV$49.1B45.0%

VHT$19.1B17.5%

36 others$40.4B37.0%

Health care ETF AUM · Nov 4, 2026

XPH Fee per $100 vs Peers

Today

$0.35a year
per $100

$35 a year on $10,000

XLV$0.08

VHT$0.09

XPH$0.35

XBI$0.35

IYH$0.37

IXJ$0.38

Expense ratio · Health care peers · Nov 4, 2026

Inside XPH

62 holdings · as of Nov 1, 2026

XPH

State Street SPDR S&P Pharmaceuticals ETF

Today

Biotechnology51.1%MANE2.9%XERS2.8%MAZE2.3%SEPN2.2%LGND2.2%INVA2.0%DFTXOMERHRMYEWTX1.8%TARS1.8%AMLX1.8%MBX1.7%21 more holdings22.3% of the fundDrug Manufacturers - Specialty29.5%PCRX2.5%AMRX2.5%VTRS2.3%PRGO2.2%ZTS2.1%ANIP2.1%INDVCOLLSUPN2.0%ELAN2.0%ETON1.8%AMPHHROWPAHC2 moreDrug Manufacturers - General12.5%LLY2.4%PFE2.1%JNJ2.0%OGN2.0%MRK2.0%BMY1.9%Medical - Pharmaceuticals6.9%RPRXPBHCORTLQDA

Biotechnology51.1%MANEXERSMAZESEPNLGNDINVA29 more holdings36.7% of the fundDrug Manufacturers - Specialty29.5%PCRXAMRXVTRSPRGOZTSANIP10 more holdings15.9% of the fundDrug Manufacturers - General12.5%LLYPFEJNJOGNMRKBMYMedical - Pharmaceuticals6.9%RPRXPBHCORTLQDA

#	Ticker	Company	Weight ▼
1	MANE	Veradermics	2.86%
2	XERS	Xeris Biopharma	2.76%
3	PCRX	Pacira Biosciences	2.51%
4	AMRX	Amneal Pharmaceuticals	2.45%
5	LLY	ELI Lilly +	2.42%
6	VTRS	Viatris	2.31%
7	MAZE	MAZE Therapeutics	2.29%
8	SEPN	Septerna	2.21%
9	PRGO	Perrigo	2.20%
10	LGND	Ligand Pharmaceuticals	2.18%

BiotechnologyDrug Manufacturers - SpecialtyDrug Manufacturers - GeneralMedical - Pharmaceuticals

SPDR XPH · current holdings by weight · as of Nov 1, 2026 · each tile is one holding · top 20 = 44.7%

How It Compares

XPH

State Street SPDR S&P Pharmaceuticals ETF’s Peers

YTD


XLV	SPDRRead Desk	0.08%	+20.4%	+29.7%	$49.1B
VHT	VanguardRead Desk	0.09%	+19.6%	+28.1%	$19.1B
XBI	SPDRRead Desk	0.35%	+27.2%	+38.1%	$10.5B
IYH	iSharesRead Desk	0.37%	+19.8%	+28.6%	$4.7B
IXJ	iSharesRead Desk	0.38%	+16.0%	+24.7%	$4.6B
XPH	SPDRThis fundRead Desk	0.35%	+15.1%	+30.1%	$459M

Health care peers · YTD and past-year returns · as of Nov 4, 2026 · sorted by AUM

Head to Head

Put XPH head to head with XLV →

XLV vs XPH

YTD

XLVSPDR · Health careXPHSPDR · Health care

Year to date

+20.4%

+15.1%

XLV wins+5.2 pts

Past year

+29.7%

+30.1%

XPH wins+0.4 pts

Fee

0.08%

0.35%

XLV winslower fee

Yield

1.4%

0.4%

XLV wins+1.0 pt

AUM

$49.1B

$459M

XLV107.0× more

3–1XLV wins

SPDR XLV and SPDR XPH · year-to-date · as of Nov 4, 2026 · AUM not scored

XPH vs VOO

YTD

XPH · SPDR S&P Pharmaceuticals

+15.1%

VOO · S&P 500

+11.5%

Gap

3.6 pts

SPDR XPH and Vanguard VOO · YTD total return · as of Nov 4, 2026

XPH vs Its Peer Average

YTD

XPHAvsBPeer average

1D+1.1%+0.6%

1M+1.0%+4.0%

3M−8.1%+6.1%

YTD+15.1%+21.0%

1Y+30.1%+29.0%

3Y+87.9%+81.2%

5Y+43.0%+28.9%

4–3XPH wins

38 Health care peers · each row scaled to its leader

The Details

XPH

Risk

4/5our risk indicator

CalmerBumpier

Volatility · 1Y23.60%

Deepest drop · 1Y−16.5%

Lowest point · 5Y−23.9%

52-week range

$64.30

$47.60−13.5% from the high$74.35

SPDR XPH · past-year price moves · as of Nov 4, 2026

XPH

Fund Facts

Today

2006launched Jun 19

Tracks[…]

Exchange · CUSIPAMEX · 78464A722

StructureETF

Leverage1x

Cost on $10,000$35 a year

Go deeper

Prospectus & documents Trading & liquidity Fees & costs Distributions

SPDR XPH · fund facts · as of Nov 4, 2026

XPH

Payouts by Year

13Y

$0.0416per share, Sep 2026

Distribution yield0.4%

PaidEvery quarter

Latest ex-date · paidSep 21 · Sep 23, 2026

12 payouts added up$1.48 a share

SPDR XPH · distributions by ex-date · 2014–2026

All Fund FactsDocuments · trading · fees · every payout

Prospectus & Documents

summary prospectus · SEC 497K ↗SEC reported portfolio · 2026-06-30 ↗SEC reported portfolio · 2026-03-31 ↗SEC reported portfolio · 2025-12-31 ↗SEC reported portfolio · 2025-09-30 ↗summary prospectus · SEC 497K ↗summary prospectus · SEC 497K ↗SEC reported portfolio · 2025-06-30 ↗SEC reported portfolio · 2025-03-31 ↗SEC reported portfolio · 2024-12-31 ↗SEC reported portfolio · 2024-09-30 ↗

Trading & Liquidity

Net asset value$63.72

Premium / discount[…]

Median spread · 30D[…]

Volume today728K

Average volume · 30D223K

Shares outstanding[…]

Options[…]

Fees & Costs

Net expense ratio0.35%

Gross expense ratio[…]

Management fee[…]

Cost on $10,000 a year$35.00

Our risk indicator4/5

Estimated yearly cost excludes trading costs and assumes constant assets.

Distributions

Ex-date	Paid	Per share
Sep 21, 2026	Sep 23, 2026	$0.0416
Jun 22, 2026	Jun 24, 2026	$0.0590
Mar 23, 2026	Mar 25, 2026	$0.0610
Dec 22, 2025	Dec 24, 2025	$0.11
Sep 22, 2025	Sep 24, 2025	$0.10
Jun 23, 2025	Jun 25, 2025	$0.0959
Mar 24, 2025	Mar 26, 2025	$0.15
Dec 23, 2024	Dec 26, 2024	$0.15
Sep 23, 2024	Sep 25, 2024	$0.19
Jun 24, 2024	Jun 26, 2024	$0.16
Mar 18, 2024	Mar 21, 2024	$0.17
Dec 18, 2023	Dec 21, 2023	$0.17

Issuer contentFrom SPDRHear the strategy from the people behind XPH.No issuer videos have been published for this fund.Are you the issuer? Claim this fund →